Type 1 diabetes mellitus in children is progressively younger, and there is a lack of quality standardized studies on specific self-reported outcomes scales for pediatric and adolescent patients.

To evaluate the measurements properties of children's type 1 diabetes-specific self-reported outcomes reports and the methodological quality of related researches based on the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN).

CNKI, Wanfang Data, VIP, Medline, Web of Science and Embase were searched for the studies on the development of children's type 1 diabetes-specific self-reported outcomes scales and validation of the measurements properties from inception to March, 2023. Two investigators cross-screened, checked and extracted the data, described and evaluated the included scales and researches by COSMIN list, to finally form the recommendations.

A total of 24 development or validation studies related to 11 children's type 1 diabetes-specific self-reported outcomes scales were included. Pediatric Quality of Life Inventory 3.2 Diabetes Module (PedsQL^TM3.2-DM), MIND Youth Questionnaire (MY-Q), Diabetes Quality of Life for Youths (DQOL-Y), Problem Areas in Diabetes-Teen Version (PAID-Teens), DISABKIDS Diabetes-Specific Module (DSM-10), FinDiab Quality-of-life Questionnaire (FDQL) and the Quality of Life Survey for Children and Adolescents with Diabetes in Chongqing are all recommended as Grade B, while PedsQL^TM3.0-DM, Problem Areas in Diabetes Survey-Pediatric Version (PAID-Peds), Type 1 Diabetes and Life (T1DAL) and ADDQoL-Teen are all recommended as Grade C. At the same time, the measurement properties of the children's type 1 diabetes-specific self-reported outcomes scales were insufficient and the reports were not comprehensive.

The methodological quality and measurement properties of the ratings of children's type 1 diabetes-specific self-reported outcomes scales at home and abroad are mostly grades B and C, which need to be further improved, and some potential scales deserve further study and application.

儿童1型糖尿病逐渐呈现低龄化趋势，儿童青少年患者的特异性自我报告结局量表缺乏方法学质量的标准化研究。

本研究基于共识选择健康测量工具的标准方法（COSMIN），评价儿童1型糖尿病特异性自我报告结局量表的测量属性和其研究的方法学质量。

检索中国知网、万方数据知识服务平台、维普中文科技期刊全文数据库、Medline、Web of Science以及Embase等数据库，限定检索年限为建库至2023年3月，获取开发儿童1型糖尿病特异性自我报告结局量表或验证其测量属性的研究，由两位研究者交叉筛选、核对与提取，并使用COSMIN清单描述评价纳入量表及其研究，形成推荐意见。

本文共纳入11个与儿童1型糖尿病特异性自我报告结局量表相关的24篇开发或验证性文章，通过评估，儿童生活质量量表（PedsQL）^TM3.2糖尿病模块（PedsQL^TM3.2-DM）、青年MIND问卷（MY-Q）、青少年儿童糖尿病生存质量量表（DQOL-Y）、糖尿病问题领域-青少年版（PAID-Teens）、DISABKIDS糖尿病专用模板（DSM-10）、FinDiab声明质量问卷（FDQL）和重庆地区儿童青少年糖尿病患者生存质量调查量表为B级推荐量表，PedsQL^TM3.0糖尿病模块（PedsQL^TM3.0-DM）、糖尿病问题领域-儿科版/青少年版（PAID-Peds）、1型糖尿病和生活问卷（T1DAL）和糖尿病依赖的成人生命质量-青少年版（ADDQoL-Teen）为C级推荐量表；同时，纳入研究的量表存在测量属性研究不足、报告不全面等问题。

国内外现有儿童1型糖尿病特异性自我报告结局量表测量属性研究的方法学质量和测量属性评级多为B、C级，有待进一步提高，部分潜力量表值得深入研究和应用。